| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Broadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong Price
For the Reasons Described in the Presentation, Broadwood Urges All Stockholders to Vote "AGAINST" the Proposed Merger
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood"), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwood's GREEN Proxy Card "AGAINST" the proposed acquisition of the Company by an affiliate of Alcon Inc. (NYSE: ALC) on the terms announced on August 5, 2025.
